Sinoma Science & TechnologyLtd（002080）株式概要中馬科学技術有限公司は、中国において特殊繊維複合材料の研究開発、設計、製造、販売を行っています。 詳細002080 ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長3/6過去の実績3/6財務の健全性4/6配当金3/6報酬収益は年間33.86%増加すると予測されています 過去1年間で収益は89%増加しました リスク分析CN市場と比較して、過去 3 か月間の株価の変動が非常に大きい財務結果に影響を与える大きな一時的項目 0.51%の配当はフリーキャッシュフローで十分にカバーされていない 多額の負債を抱えている すべてのリスクチェックを見る002080 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW496,749 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINROAG496,749 investors already sharing narrativesYour Fair ValueCN¥Current PriceCN¥85.0924.5% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture058b2016201920222025202620282031Revenue CN¥58.0bEarnings CN¥3.6bAdvancedSet Fair ValueView all narrativesSinoma Science & Technology Co.,Ltd. 競合他社Zhejiang JuhuaSymbol: SHSE:600160Market cap: CN¥133.2bHengli PetrochemicalLtdSymbol: SHSE:600346Market cap: CN¥125.3bRongsheng PetrochemicalSymbol: SZSE:002493Market cap: CN¥111.8bGuangzhou Tinci Materials TechnologySymbol: SZSE:002709Market cap: CN¥109.6b価格と性能株価の高値、安値、推移の概要Sinoma Science & TechnologyLtd過去の株価現在の株価CN¥85.0952週高値CN¥102.2252週安値CN¥22.31ベータ1.621ヶ月の変化35.64%3ヶ月変化114.22%1年変化283.12%3年間の変化318.13%5年間の変化194.94%IPOからの変化2,286.88%最新ニュースお知らせ • Jun 30Sinoma Science & Technology Co.,Ltd. to Report First Half, 2026 Results on Aug 22, 2026Sinoma Science & Technology Co.,Ltd. announced that they will report first half, 2026 results on Aug 22, 2026Valuation Update With 7 Day Price Move • Jun 30Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥90.00, the stock trades at a forward P/E ratio of 47x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 358% over the past three years.New Risk • Jun 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risks High level of debt (57% net debt to equity). Dividend is not well covered by cash flows (211% cash payout ratio). Large one-off items impacting financial results.Valuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥68.11, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 250% over the past three years.Declared Dividend • May 27Dividend of CN¥0.43 announcedShareholders will receive a dividend of CN¥0.43. Ex-date: 29th May 2026 Payment date: 29th May 2026 Dividend yield will be 0.6%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (37% earnings payout ratio) but not covered by cash flows (211% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 120% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Valuation Update With 7 Day Price Move • May 26Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥74.24, the stock trades at a forward P/E ratio of 38x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 303% over the past three years.最新情報をもっと見るRecent updatesお知らせ • Jun 30Sinoma Science & Technology Co.,Ltd. to Report First Half, 2026 Results on Aug 22, 2026Sinoma Science & Technology Co.,Ltd. announced that they will report first half, 2026 results on Aug 22, 2026Valuation Update With 7 Day Price Move • Jun 30Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥90.00, the stock trades at a forward P/E ratio of 47x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 358% over the past three years.New Risk • Jun 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risks High level of debt (57% net debt to equity). Dividend is not well covered by cash flows (211% cash payout ratio). Large one-off items impacting financial results.Valuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥68.11, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 250% over the past three years.Declared Dividend • May 27Dividend of CN¥0.43 announcedShareholders will receive a dividend of CN¥0.43. Ex-date: 29th May 2026 Payment date: 29th May 2026 Dividend yield will be 0.6%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (37% earnings payout ratio) but not covered by cash flows (211% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 120% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Valuation Update With 7 Day Price Move • May 26Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥74.24, the stock trades at a forward P/E ratio of 38x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 303% over the past three years.Valuation Update With 7 Day Price Move • May 12Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥65.99, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 246% over the past three years.Price Target Changed • Apr 26Price target increased by 11% to CN¥56.68Up from CN¥50.89, the current price target is an average from 3 analysts. New target price is 7.9% above last closing price of CN¥52.52. Stock is up 266% over the past year. The company is forecast to post earnings per share of CN¥1.46 for next year compared to CN¥1.08 last year.Reported Earnings • Apr 25First quarter 2026 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2026 results: EPS: CN¥0.30 (up from CN¥0.22 in 1Q 2025). Revenue: CN¥6.85b (up 25% from 1Q 2025). Net income: CN¥507.5m (up 40% from 1Q 2025). Profit margin: 7.4% (up from 6.6% in 1Q 2025). Revenue exceeded analyst estimates by 16%. Earnings per share (EPS) also surpassed analyst estimates by 12%. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 36% per year, which means it is well ahead of earnings.New Risk • Apr 13New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10% average weekly change). Minor Risks High level of debt (49% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improves as stock rises 26%After last week's 26% share price gain to CN¥50.14, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 24x in the Chemicals industry in China. Total returns to shareholders of 114% over the past three years.お知らせ • Mar 31Sinoma Science & Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 24, 2026Sinoma Science & Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026New Risk • Mar 23New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 41% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks High level of debt (49% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (9.6% average weekly change). Large one-off items impacting financial results.Reported Earnings • Mar 20Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: CN¥1.08 (up from CN¥0.53 in FY 2024). Revenue: CN¥30.2b (up 26% from FY 2024). Net income: CN¥1.82b (up 104% from FY 2024). Profit margin: 6.0% (up from 3.7% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.3%. Revenue is forecast to grow 9.0% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.お知らせ • Mar 19Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 09, 2026Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 09, 2026, at 16:30 China Standard Time. Location: 12F, Building 7, Yard No. 6, North Street, Dongsheng Science and Technology Park, Haidian District, Beijing ChinaPrice Target Changed • Feb 14Price target increased by 17% to CN¥43.36Up from CN¥37.11, the current price target is an average from 3 analysts. New target price is 9.3% below last closing price of CN¥47.81. Stock is up 286% over the past year. The company is forecast to post earnings per share of CN¥1.12 for next year compared to CN¥0.53 last year.New Risk • Feb 12New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 9.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.9% average weekly change). Minor Risks High level of debt (48% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improves as stock rises 29%After last week's 29% share price gain to CN¥49.87, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 129% over the past three years.お知らせ • Dec 31Sinoma Science & Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Mar 20, 2026Sinoma Science & Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Mar 20, 2026Valuation Update With 7 Day Price Move • Dec 25Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥39.57, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 25x in the Chemicals industry in China. Total returns to shareholders of 100% over the past three years.Valuation Update With 7 Day Price Move • Oct 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥35.33, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 24x in the Chemicals industry in China. Total returns to shareholders of 111% over the past three years.Reported Earnings • Oct 22Third quarter 2025 earnings released: EPS: CN¥0.29 (vs CN¥0.086 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.29 (up from CN¥0.086 in 3Q 2024). Revenue: CN¥8.37b (up 34% from 3Q 2024). Net income: CN¥481.1m (up 235% from 3Q 2024). Profit margin: 5.7% (up from 2.3% in 3Q 2024). Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.お知らせ • Sep 30+ 2 more updatesSinoma Science & Technology Co.,Ltd. to Report Q3, 2025 Results on Oct 22, 2025Sinoma Science & Technology Co.,Ltd. announced that they will report Q3, 2025 results on Oct 22, 2025Price Target Changed • Sep 24Price target increased by 39% to CN¥36.87Up from CN¥26.50, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of CN¥35.55. Stock is up 249% over the past year. The company is forecast to post earnings per share of CN¥1.23 for next year compared to CN¥0.53 last year.Valuation Update With 7 Day Price Move • Sep 04Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥31.05, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 45% over the past three years.New Risk • Sep 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 8.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.7% average weekly change). Minor Risks High level of debt (52% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.Reported Earnings • Aug 24Second quarter 2025 earnings released: EPS: CN¥0.38 (vs CN¥0.15 in 2Q 2024)Second quarter 2025 results: EPS: CN¥0.38 (up from CN¥0.15 in 2Q 2024). Revenue: CN¥7.83b (up 28% from 2Q 2024). Net income: CN¥636.6m (up 155% from 2Q 2024). Profit margin: 8.1% (up from 4.1% in 2Q 2024). Revenue is forecast to grow 8.8% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥32.00, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 34% over the past three years.New Risk • Jul 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.7% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.1% net profit margin).Valuation Update With 7 Day Price Move • Jul 21Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥28.44, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 12% over the past three years.Price Target Changed • Jul 13Price target increased by 21% to CN¥20.69Up from CN¥17.09, the current price target is an average from 4 analysts. New target price is 13% below last closing price of CN¥23.76. Stock is up 109% over the past year. The company is forecast to post earnings per share of CN¥1.02 for next year compared to CN¥0.53 last year.お知らせ • Jul 02Sinoma Science & Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 22, 2025Sinoma Science & Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 22, 2025Price Target Changed • Jul 01Price target increased by 12% to CN¥18.26Up from CN¥16.34, the current price target is an average from 4 analysts. New target price is 15% below last closing price of CN¥21.45. Stock is up 68% over the past year. The company is forecast to post earnings per share of CN¥0.99 for next year compared to CN¥0.53 last year.Valuation Update With 7 Day Price Move • Jul 01Investor sentiment improves as stock rises 19%After last week's 19% share price gain to CN¥21.45, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 22x in the Chemicals industry in China. Total loss to shareholders of 16% over the past three years.Declared Dividend • May 25Dividend reduced to CN¥0.23Dividend of CN¥0.23 is 60% lower than last year. Ex-date: 30th May 2025 Payment date: 30th May 2025 Dividend yield will be 1.4%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (36% earnings payout ratio) and cash flows (27% cash payout ratio). The dividend has increased by an average of 15% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 103% over the next 3 years, which should provide support to the dividend and adequate earnings cover.New Risk • Apr 26New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.8x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.1% net profit margin).Reported Earnings • Apr 24First quarter 2025 earnings released: EPS: CN¥0.22 (vs CN¥0.13 in 1Q 2024)First quarter 2025 results: EPS: CN¥0.22 (up from CN¥0.13 in 1Q 2024). Revenue: CN¥5.51b (up 24% from 1Q 2024). Net income: CN¥362.1m (up 68% from 1Q 2024). Profit margin: 6.6% (up from 4.9% in 1Q 2024). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.お知らせ • Apr 12+ 1 more updateSinoma Science & Technology Co.,Ltd. Approves the Election of Ni Jinrui as DirectorSinoma Science & Technology Co.,Ltd. at its Annual General Meeting held on 10 April 2025 approved the election of Ni Jinrui as a director.Valuation Update With 7 Day Price Move • Apr 08Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥13.02, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 36% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥21.11 per share.お知らせ • Mar 31Sinoma Science & Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 24, 2025Sinoma Science & Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025Price Target Changed • Mar 28Price target increased by 12% to CN¥17.09Up from CN¥15.27, the current price target is an average from 4 analysts. New target price is 16% above last closing price of CN¥14.73. Stock is down 4.3% over the past year. The company is forecast to post earnings per share of CN¥0.94 for next year compared to CN¥0.53 last year.Major Estimate Revision • Mar 26Consensus EPS estimates increase by 12%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has improved. 2025 revenue forecast increased from CN¥27.7b to CN¥28.9b. EPS estimate increased from CN¥0.845 to CN¥0.95 per share. Net income forecast to grow 78% next year vs 49% growth forecast for Chemicals industry in China. Consensus price target up from CN¥15.27 to CN¥16.34. Share price was steady at CN¥14.76 over the past week.New Risk • Mar 22New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.9x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.9x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.7% net profit margin).Price Target Changed • Mar 20Price target increased by 14% to CN¥16.35Up from CN¥14.31, the current price target is an average from 5 analysts. New target price is 11% above last closing price of CN¥14.78. Stock is down 3.8% over the past year. The company is forecast to post earnings per share of CN¥0.95 for next year compared to CN¥0.53 last year.Reported Earnings • Mar 20Full year 2024 earnings: EPS misses analyst expectationsFull year 2024 results: EPS: CN¥0.53 (down from CN¥1.33 in FY 2023). Revenue: CN¥24.0b (down 7.4% from FY 2023). Net income: CN¥891.9m (down 60% from FY 2023). Profit margin: 3.7% (down from 8.6% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 12%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.お知らせ • Mar 20Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 10, 2025Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 10, 2025, at 16:30 China Standard Time. Location: The Company's Meeting Room, Beijing ChinaValuation Update With 7 Day Price Move • Feb 24Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥14.66, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 21x in the Chemicals industry in China. Total loss to shareholders of 46% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥6.31 per share.Price Target Changed • Jan 07Price target increased by 9.9% to CN¥13.55Up from CN¥12.33, the current price target is an average from 5 analysts. New target price is 8.0% above last closing price of CN¥12.54. Stock is down 16% over the past year. The company is forecast to post earnings per share of CN¥0.67 for next year compared to CN¥1.33 last year.お知らせ • Dec 31Sinoma Science & Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Mar 20, 2025Sinoma Science & Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Mar 20, 2025Major Estimate Revision • Nov 20Consensus EPS estimates increase by 11%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate increased from CN¥0.625 to CN¥0.691. Revenue forecast steady at CN¥23.9b. Net income forecast to grow 40% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target up from CN¥12.33 to CN¥12.83. Share price fell 6.1% to CN¥13.30 over the past week.お知らせ • Nov 15Sinoma Science & Technology Co.,Ltd. Appoints Feng Jun as DirectorSinoma Science & Technology Co.,Ltd. held its 4th Extraordinary General Meeting of 2024 on 13 November 2024 were approved; Election of Feng Jun as a director.Reported Earnings • Oct 26Third quarter 2024 earnings released: EPS: CN¥0.086 (vs CN¥0.19 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.086 (down from CN¥0.19 in 3Q 2023). Revenue: CN¥6.27b (up 7.1% from 3Q 2023). Net income: CN¥143.7m (down 55% from 3Q 2023). Profit margin: 2.3% (down from 5.4% in 3Q 2023). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year whereas the company’s share price has fallen by 30% per year.お知らせ • Sep 30Sinoma Science & Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 25, 2024Sinoma Science & Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥11.61, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 64% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥8.71 per share.Buy Or Sell Opportunity • Sep 26Now 24% overvaluedOver the last 90 days, the stock has fallen 16% to CN¥10.86. The fair value is estimated to be CN¥8.73, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.7% over the last 3 years. Earnings per share has declined by 17%. Revenue is forecast to grow by 35% in 2 years. Earnings are forecast to grow by 70% in the next 2 years.お知らせ • Sep 11Sinoma Science & Technology Co.,Ltd. Approves Board ElectionsSinoma Science & Technology Co.,Ltd. at its EGM held on September 9, 2024 approved election of Zhuang Qinxia as director and Wang Guanyu as independent director.Major Estimate Revision • Aug 28Consensus revenue estimates fall by 14%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥28.7b to CN¥24.7b. EPS estimate fell from CN¥1.38 to CN¥0.79 per share. Net income forecast to grow 27% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target down from CN¥17.92 to CN¥11.69. Share price fell 2.5% to CN¥9.68 over the past week.Reported Earnings • Aug 22Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: CN¥0.15 (down from CN¥0.58 in 2Q 2023). Revenue: CN¥6.11b (down 17% from 2Q 2023). Net income: CN¥248.4m (down 75% from 2Q 2023). Profit margin: 4.1% (down from 13% in 2Q 2023). Revenue missed analyst estimates by 32%. Earnings per share (EPS) also missed analyst estimates by 62%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has fallen by 30% per year, which means it is performing significantly worse than earnings.Major Estimate Revision • Aug 09Consensus EPS estimates fall by 14%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥29.1b to CN¥28.7b. EPS estimate also fell from CN¥1.61 per share to CN¥1.38 per share. Net income forecast to grow 21% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target down from CN¥22.58 to CN¥17.92. Share price was steady at CN¥11.11 over the past week.Price Target Changed • Aug 06Price target decreased by 20% to CN¥17.92Down from CN¥22.52, the current price target is an average from 4 analysts. New target price is 60% above last closing price of CN¥11.22. Stock is down 50% over the past year. The company is forecast to post earnings per share of CN¥1.51 for next year compared to CN¥1.33 last year.お知らせ • Jun 29Sinoma Science & Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 22, 2024Sinoma Science & Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 22, 2024Declared Dividend • May 27Dividend reduced to CN¥0.56Dividend of CN¥0.56 is 15% lower than last year. Ex-date: 31st May 2024 Payment date: 31st May 2024 Dividend yield will be 3.6%, which is higher than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (46% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 28% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 66% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • May 26Sinoma Science & Technology Co.,Ltd. Announces Final Cash Dividend on A Shares for 2023, Payable on 31 May 2024Sinoma Science & Technology Co.,Ltd. announced 2023 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 5.60000000. Record date: 30 May 2024; Ex-date: 31 May 2024; Payment date: 31 May 2024.お知らせ • May 15Sinoma Science & Technology Co.,Ltd. Elects Zhang Wenjin as a DirectorSinoma Science & Technology Co.,Ltd. held its first Extraordinary General Meeting of 2024 on 13 May 2024, elected Zhang Wenjin as a director.Major Estimate Revision • May 07Consensus EPS estimates increase by 15%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate increased from CN¥1.49 to CN¥1.71. Revenue forecast unchanged at CN¥29.7b. Net income forecast to grow 45% next year vs 54% growth forecast for Chemicals industry in China. Consensus price target of CN¥23.26 unchanged from last update. Share price rose 7.3% to CN¥16.66 over the past week.Reported Earnings • Apr 26First quarter 2024 earnings: EPS and revenues miss analyst expectationsFirst quarter 2024 results: EPS: CN¥0.13 (down from CN¥0.25 in 1Q 2023). Revenue: CN¥4.43b (up 4.1% from 1Q 2023). Net income: CN¥216.2m (down 48% from 1Q 2023). Profit margin: 4.9% (down from 9.8% in 1Q 2023). Revenue missed analyst estimates by 14%. Earnings per share (EPS) also missed analyst estimates by 58%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 11% per year.お知らせ • Mar 30Sinoma Science & Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024Sinoma Science & Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024Major Estimate Revision • Mar 28Consensus EPS estimates fall by 27%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥30.1b to CN¥28.8b. EPS estimate also fell from CN¥2.04 per share to CN¥1.48 per share. Net income forecast to grow 12% next year vs 54% growth forecast for Chemicals industry in China. Consensus price target down from CN¥27.21 to CN¥22.52. Share price was steady at CN¥15.08 over the past week.お知らせ • Mar 23Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 12, 2024Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 12, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Beijing China Agenda: To consider 2023 annual report and its summary; to consider 2023 work report of the board of directors; to consider 2023 work report of the supervisory committee; to consider 2023 annual accounts report; to consider 2023 profit distribution plan; to consider 2024 estimated continuing connected transactions; to consider Amendments to the system for independent directors; to consider Amendments to the Company's articles of association; to consider 2024 loan budget and authorization for relevant loans; to consider Application for registration and issuance of not more than CNY 4.8 billion super and short-term commercial papers at a proper time; to consider Application for registration and issuance of not more than CNY 0.9 billion commercial papers; to consider Reappointment of 2024 audit firm; to consider Election of Wang Li as a supervisor.New Risk • Mar 23New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 22% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks High level of debt (43% net debt to equity). Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (8.6% net profit margin).Price Target Changed • Mar 22Price target decreased by 11% to CN¥25.94Down from CN¥29.11, the current price target is an average from 5 analysts. New target price is 70% above last closing price of CN¥15.27. Stock is down 39% over the past year. The company is forecast to post earnings per share of CN¥1.49 for next year compared to CN¥1.33 last year.Reported Earnings • Mar 22Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2023 results: EPS: CN¥1.33 (down from CN¥2.09 in FY 2022). Revenue: CN¥25.9b (up 17% from FY 2022). Net income: CN¥2.22b (down 37% from FY 2022). Profit margin: 8.6% (down from 16% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.6%. Earnings per share (EPS) missed analyst estimates by 15%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings.Buy Or Sell Opportunity • Feb 06Now 29% overvaluedOver the last 90 days, the stock has fallen 21% to CN¥13.94. The fair value is estimated to be CN¥10.77, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.7% over the last 3 years. Earnings per share has grown by 11%. Revenue is forecast to grow by 49% in 2 years. Earnings are forecast to grow by 46% in the next 2 years.Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥12.68, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥10.87 per share.お知らせ • Dec 30Sinoma Science & Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 22, 2024Sinoma Science & Technology Co.,Ltd. announced that they will report fiscal year 2023 results on Mar 22, 2024Major Estimate Revision • Oct 30Consensus EPS estimates fall by 33%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥26.2b to CN¥25.7b. EPS estimate also fell from CN¥2.01 per share to CN¥1.34 per share. Net income forecast to grow 17% next year vs 60% growth forecast for Chemicals industry in China. Consensus price target down from CN¥29.11 to CN¥27.81. Share price fell 5.3% to CN¥17.28 over the past week.New Risk • Oct 24New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 18% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (18% operating cash flow to total debt). High level of non-cash earnings (22% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows.New Risk • Aug 19New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 20% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (20% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows.株主還元002080CN ChemicalsCN 市場7D-12.9%-1.3%0.4%1Y283.1%63.9%27.7%株主還元を見る業界別リターン: 002080過去 1 年間で63.9 % の収益を上げたCN Chemicals業界を上回りました。リターン対市場: 002080過去 1 年間で27.7 % の収益を上げたCN市場を上回りました。価格変動Is 002080's price volatile compared to industry and market?002080 volatility002080 Average Weekly Movement12.0%Chemicals Industry Average Movement7.3%Market Average Movement6.8%10% most volatile stocks in CN Market11.1%10% least volatile stocks in CN Market4.2%安定した株価: 002080の株価は、 CN市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 002080の weekly volatility ( 12% ) は過去 1 年間安定していますが、依然としてCNの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト200119,955Yu Chenwww.sinomatech.com中馬科学技術有限公司は、中国で特殊繊維複合材料の研究開発、設計、製造、販売を行っている。同社は、航空宇宙、船舶、軌道輸送、自動車、インフラ建設、電力、化学腐食などの分野で使用されるガラス繊維、三次元織物、フェノール樹脂、複合金型、電力複合材料、鉄道輸送複合材料、自動車複合材料などの特殊繊維および複合材料を提供している。また、リチウム電池用セパレーターやリチウム電池材料、車両制御用CNGボンベ、自動車用鋼製深絞りCNGボンベ、チューブ束、水素ボンベなどの高圧ガスボンベ、防衛、軍事、環境保護、農業、プラスチック、ゴム、高圧ケーブルなどの産業用途に使用されるエンジニアリング技術・設備、セメント、鉄鋼、カーボンブラック、電力などの産業用途に使用されるエアダスト、フィルター材料、バッテリーセパレーターなどのろ過・分離材料、複合風力発電ブレードなども提供している。同社は製品を米国、日本、および海外に輸出している。中馬科学技術有限公司は2001年に設立され、中国北京に本社を置く。中馬科学技術有限公司は中国建築材料有限公司の子会社として運営されている。もっと見るSinoma Science & Technology Co.,Ltd. 基礎のまとめSinoma Science & TechnologyLtd の収益と売上を時価総額と比較するとどうか。002080 基礎統計学時価総額CN¥142.79b収益（TTM）CN¥1.96b売上高(TTM)CN¥31.54b72.7xPER（株価収益率4.5xP/Sレシオ002080 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計002080 損益計算書（TTM）収益CN¥31.54b売上原価CN¥25.53b売上総利益CN¥6.02bその他の費用CN¥4.05b収益CN¥1.96b直近の収益報告Mar 31, 2026次回決算日Aug 22, 2026一株当たり利益（EPS）1.17グロス・マージン19.07%純利益率6.22%有利子負債／自己資本比率62.7%002080 の長期的なパフォーマンスは？過去の実績と比較を見る配当金0.5%現在の配当利回り37%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/05 04:10終値2026/07/03 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Sinoma Science & Technology Co.,Ltd. 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。12 アナリスト機関Edward LeungBofA Global ResearchJiachen LiuChina International Capital Corporation LimitedSophia ZhangChina Stock Investment Research Co. Ltd. (GZ500..com)9 その他のアナリストを表示
お知らせ • Jun 30Sinoma Science & Technology Co.,Ltd. to Report First Half, 2026 Results on Aug 22, 2026Sinoma Science & Technology Co.,Ltd. announced that they will report first half, 2026 results on Aug 22, 2026
Valuation Update With 7 Day Price Move • Jun 30Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥90.00, the stock trades at a forward P/E ratio of 47x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 358% over the past three years.
New Risk • Jun 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risks High level of debt (57% net debt to equity). Dividend is not well covered by cash flows (211% cash payout ratio). Large one-off items impacting financial results.
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥68.11, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 250% over the past three years.
Declared Dividend • May 27Dividend of CN¥0.43 announcedShareholders will receive a dividend of CN¥0.43. Ex-date: 29th May 2026 Payment date: 29th May 2026 Dividend yield will be 0.6%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (37% earnings payout ratio) but not covered by cash flows (211% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 120% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Valuation Update With 7 Day Price Move • May 26Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥74.24, the stock trades at a forward P/E ratio of 38x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 303% over the past three years.
お知らせ • Jun 30Sinoma Science & Technology Co.,Ltd. to Report First Half, 2026 Results on Aug 22, 2026Sinoma Science & Technology Co.,Ltd. announced that they will report first half, 2026 results on Aug 22, 2026
Valuation Update With 7 Day Price Move • Jun 30Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥90.00, the stock trades at a forward P/E ratio of 47x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 358% over the past three years.
New Risk • Jun 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risks High level of debt (57% net debt to equity). Dividend is not well covered by cash flows (211% cash payout ratio). Large one-off items impacting financial results.
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥68.11, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 250% over the past three years.
Declared Dividend • May 27Dividend of CN¥0.43 announcedShareholders will receive a dividend of CN¥0.43. Ex-date: 29th May 2026 Payment date: 29th May 2026 Dividend yield will be 0.6%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (37% earnings payout ratio) but not covered by cash flows (211% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 120% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Valuation Update With 7 Day Price Move • May 26Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥74.24, the stock trades at a forward P/E ratio of 38x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 303% over the past three years.
Valuation Update With 7 Day Price Move • May 12Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥65.99, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 246% over the past three years.
Price Target Changed • Apr 26Price target increased by 11% to CN¥56.68Up from CN¥50.89, the current price target is an average from 3 analysts. New target price is 7.9% above last closing price of CN¥52.52. Stock is up 266% over the past year. The company is forecast to post earnings per share of CN¥1.46 for next year compared to CN¥1.08 last year.
Reported Earnings • Apr 25First quarter 2026 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2026 results: EPS: CN¥0.30 (up from CN¥0.22 in 1Q 2025). Revenue: CN¥6.85b (up 25% from 1Q 2025). Net income: CN¥507.5m (up 40% from 1Q 2025). Profit margin: 7.4% (up from 6.6% in 1Q 2025). Revenue exceeded analyst estimates by 16%. Earnings per share (EPS) also surpassed analyst estimates by 12%. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 36% per year, which means it is well ahead of earnings.
New Risk • Apr 13New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10% average weekly change). Minor Risks High level of debt (49% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.
Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improves as stock rises 26%After last week's 26% share price gain to CN¥50.14, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 24x in the Chemicals industry in China. Total returns to shareholders of 114% over the past three years.
お知らせ • Mar 31Sinoma Science & Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 24, 2026Sinoma Science & Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026
New Risk • Mar 23New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 41% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks High level of debt (49% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (9.6% average weekly change). Large one-off items impacting financial results.
Reported Earnings • Mar 20Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: CN¥1.08 (up from CN¥0.53 in FY 2024). Revenue: CN¥30.2b (up 26% from FY 2024). Net income: CN¥1.82b (up 104% from FY 2024). Profit margin: 6.0% (up from 3.7% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.3%. Revenue is forecast to grow 9.0% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
お知らせ • Mar 19Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 09, 2026Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 09, 2026, at 16:30 China Standard Time. Location: 12F, Building 7, Yard No. 6, North Street, Dongsheng Science and Technology Park, Haidian District, Beijing China
Price Target Changed • Feb 14Price target increased by 17% to CN¥43.36Up from CN¥37.11, the current price target is an average from 3 analysts. New target price is 9.3% below last closing price of CN¥47.81. Stock is up 286% over the past year. The company is forecast to post earnings per share of CN¥1.12 for next year compared to CN¥0.53 last year.
New Risk • Feb 12New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 9.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.9% average weekly change). Minor Risks High level of debt (48% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.
Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improves as stock rises 29%After last week's 29% share price gain to CN¥49.87, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 129% over the past three years.
お知らせ • Dec 31Sinoma Science & Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Mar 20, 2026Sinoma Science & Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Mar 20, 2026
Valuation Update With 7 Day Price Move • Dec 25Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥39.57, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 25x in the Chemicals industry in China. Total returns to shareholders of 100% over the past three years.
Valuation Update With 7 Day Price Move • Oct 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥35.33, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 24x in the Chemicals industry in China. Total returns to shareholders of 111% over the past three years.
Reported Earnings • Oct 22Third quarter 2025 earnings released: EPS: CN¥0.29 (vs CN¥0.086 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.29 (up from CN¥0.086 in 3Q 2024). Revenue: CN¥8.37b (up 34% from 3Q 2024). Net income: CN¥481.1m (up 235% from 3Q 2024). Profit margin: 5.7% (up from 2.3% in 3Q 2024). Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
お知らせ • Sep 30+ 2 more updatesSinoma Science & Technology Co.,Ltd. to Report Q3, 2025 Results on Oct 22, 2025Sinoma Science & Technology Co.,Ltd. announced that they will report Q3, 2025 results on Oct 22, 2025
Price Target Changed • Sep 24Price target increased by 39% to CN¥36.87Up from CN¥26.50, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of CN¥35.55. Stock is up 249% over the past year. The company is forecast to post earnings per share of CN¥1.23 for next year compared to CN¥0.53 last year.
Valuation Update With 7 Day Price Move • Sep 04Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥31.05, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 45% over the past three years.
New Risk • Sep 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 8.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.7% average weekly change). Minor Risks High level of debt (52% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.
Reported Earnings • Aug 24Second quarter 2025 earnings released: EPS: CN¥0.38 (vs CN¥0.15 in 2Q 2024)Second quarter 2025 results: EPS: CN¥0.38 (up from CN¥0.15 in 2Q 2024). Revenue: CN¥7.83b (up 28% from 2Q 2024). Net income: CN¥636.6m (up 155% from 2Q 2024). Profit margin: 8.1% (up from 4.1% in 2Q 2024). Revenue is forecast to grow 8.8% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥32.00, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 34% over the past three years.
New Risk • Jul 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.7% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.1% net profit margin).
Valuation Update With 7 Day Price Move • Jul 21Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥28.44, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 12% over the past three years.
Price Target Changed • Jul 13Price target increased by 21% to CN¥20.69Up from CN¥17.09, the current price target is an average from 4 analysts. New target price is 13% below last closing price of CN¥23.76. Stock is up 109% over the past year. The company is forecast to post earnings per share of CN¥1.02 for next year compared to CN¥0.53 last year.
お知らせ • Jul 02Sinoma Science & Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 22, 2025Sinoma Science & Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 22, 2025
Price Target Changed • Jul 01Price target increased by 12% to CN¥18.26Up from CN¥16.34, the current price target is an average from 4 analysts. New target price is 15% below last closing price of CN¥21.45. Stock is up 68% over the past year. The company is forecast to post earnings per share of CN¥0.99 for next year compared to CN¥0.53 last year.
Valuation Update With 7 Day Price Move • Jul 01Investor sentiment improves as stock rises 19%After last week's 19% share price gain to CN¥21.45, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 22x in the Chemicals industry in China. Total loss to shareholders of 16% over the past three years.
Declared Dividend • May 25Dividend reduced to CN¥0.23Dividend of CN¥0.23 is 60% lower than last year. Ex-date: 30th May 2025 Payment date: 30th May 2025 Dividend yield will be 1.4%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (36% earnings payout ratio) and cash flows (27% cash payout ratio). The dividend has increased by an average of 15% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 103% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
New Risk • Apr 26New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.8x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.1% net profit margin).
Reported Earnings • Apr 24First quarter 2025 earnings released: EPS: CN¥0.22 (vs CN¥0.13 in 1Q 2024)First quarter 2025 results: EPS: CN¥0.22 (up from CN¥0.13 in 1Q 2024). Revenue: CN¥5.51b (up 24% from 1Q 2024). Net income: CN¥362.1m (up 68% from 1Q 2024). Profit margin: 6.6% (up from 4.9% in 1Q 2024). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
お知らせ • Apr 12+ 1 more updateSinoma Science & Technology Co.,Ltd. Approves the Election of Ni Jinrui as DirectorSinoma Science & Technology Co.,Ltd. at its Annual General Meeting held on 10 April 2025 approved the election of Ni Jinrui as a director.
Valuation Update With 7 Day Price Move • Apr 08Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥13.02, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 36% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥21.11 per share.
お知らせ • Mar 31Sinoma Science & Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 24, 2025Sinoma Science & Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025
Price Target Changed • Mar 28Price target increased by 12% to CN¥17.09Up from CN¥15.27, the current price target is an average from 4 analysts. New target price is 16% above last closing price of CN¥14.73. Stock is down 4.3% over the past year. The company is forecast to post earnings per share of CN¥0.94 for next year compared to CN¥0.53 last year.
Major Estimate Revision • Mar 26Consensus EPS estimates increase by 12%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has improved. 2025 revenue forecast increased from CN¥27.7b to CN¥28.9b. EPS estimate increased from CN¥0.845 to CN¥0.95 per share. Net income forecast to grow 78% next year vs 49% growth forecast for Chemicals industry in China. Consensus price target up from CN¥15.27 to CN¥16.34. Share price was steady at CN¥14.76 over the past week.
New Risk • Mar 22New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.9x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.9x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.7% net profit margin).
Price Target Changed • Mar 20Price target increased by 14% to CN¥16.35Up from CN¥14.31, the current price target is an average from 5 analysts. New target price is 11% above last closing price of CN¥14.78. Stock is down 3.8% over the past year. The company is forecast to post earnings per share of CN¥0.95 for next year compared to CN¥0.53 last year.
Reported Earnings • Mar 20Full year 2024 earnings: EPS misses analyst expectationsFull year 2024 results: EPS: CN¥0.53 (down from CN¥1.33 in FY 2023). Revenue: CN¥24.0b (down 7.4% from FY 2023). Net income: CN¥891.9m (down 60% from FY 2023). Profit margin: 3.7% (down from 8.6% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 12%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.
お知らせ • Mar 20Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 10, 2025Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 10, 2025, at 16:30 China Standard Time. Location: The Company's Meeting Room, Beijing China
Valuation Update With 7 Day Price Move • Feb 24Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥14.66, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 21x in the Chemicals industry in China. Total loss to shareholders of 46% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥6.31 per share.
Price Target Changed • Jan 07Price target increased by 9.9% to CN¥13.55Up from CN¥12.33, the current price target is an average from 5 analysts. New target price is 8.0% above last closing price of CN¥12.54. Stock is down 16% over the past year. The company is forecast to post earnings per share of CN¥0.67 for next year compared to CN¥1.33 last year.
お知らせ • Dec 31Sinoma Science & Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Mar 20, 2025Sinoma Science & Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Mar 20, 2025
Major Estimate Revision • Nov 20Consensus EPS estimates increase by 11%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate increased from CN¥0.625 to CN¥0.691. Revenue forecast steady at CN¥23.9b. Net income forecast to grow 40% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target up from CN¥12.33 to CN¥12.83. Share price fell 6.1% to CN¥13.30 over the past week.
お知らせ • Nov 15Sinoma Science & Technology Co.,Ltd. Appoints Feng Jun as DirectorSinoma Science & Technology Co.,Ltd. held its 4th Extraordinary General Meeting of 2024 on 13 November 2024 were approved; Election of Feng Jun as a director.
Reported Earnings • Oct 26Third quarter 2024 earnings released: EPS: CN¥0.086 (vs CN¥0.19 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.086 (down from CN¥0.19 in 3Q 2023). Revenue: CN¥6.27b (up 7.1% from 3Q 2023). Net income: CN¥143.7m (down 55% from 3Q 2023). Profit margin: 2.3% (down from 5.4% in 3Q 2023). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year whereas the company’s share price has fallen by 30% per year.
お知らせ • Sep 30Sinoma Science & Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 25, 2024Sinoma Science & Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥11.61, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 64% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥8.71 per share.
Buy Or Sell Opportunity • Sep 26Now 24% overvaluedOver the last 90 days, the stock has fallen 16% to CN¥10.86. The fair value is estimated to be CN¥8.73, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.7% over the last 3 years. Earnings per share has declined by 17%. Revenue is forecast to grow by 35% in 2 years. Earnings are forecast to grow by 70% in the next 2 years.
お知らせ • Sep 11Sinoma Science & Technology Co.,Ltd. Approves Board ElectionsSinoma Science & Technology Co.,Ltd. at its EGM held on September 9, 2024 approved election of Zhuang Qinxia as director and Wang Guanyu as independent director.
Major Estimate Revision • Aug 28Consensus revenue estimates fall by 14%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥28.7b to CN¥24.7b. EPS estimate fell from CN¥1.38 to CN¥0.79 per share. Net income forecast to grow 27% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target down from CN¥17.92 to CN¥11.69. Share price fell 2.5% to CN¥9.68 over the past week.
Reported Earnings • Aug 22Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: CN¥0.15 (down from CN¥0.58 in 2Q 2023). Revenue: CN¥6.11b (down 17% from 2Q 2023). Net income: CN¥248.4m (down 75% from 2Q 2023). Profit margin: 4.1% (down from 13% in 2Q 2023). Revenue missed analyst estimates by 32%. Earnings per share (EPS) also missed analyst estimates by 62%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has fallen by 30% per year, which means it is performing significantly worse than earnings.
Major Estimate Revision • Aug 09Consensus EPS estimates fall by 14%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥29.1b to CN¥28.7b. EPS estimate also fell from CN¥1.61 per share to CN¥1.38 per share. Net income forecast to grow 21% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target down from CN¥22.58 to CN¥17.92. Share price was steady at CN¥11.11 over the past week.
Price Target Changed • Aug 06Price target decreased by 20% to CN¥17.92Down from CN¥22.52, the current price target is an average from 4 analysts. New target price is 60% above last closing price of CN¥11.22. Stock is down 50% over the past year. The company is forecast to post earnings per share of CN¥1.51 for next year compared to CN¥1.33 last year.
お知らせ • Jun 29Sinoma Science & Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 22, 2024Sinoma Science & Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 22, 2024
Declared Dividend • May 27Dividend reduced to CN¥0.56Dividend of CN¥0.56 is 15% lower than last year. Ex-date: 31st May 2024 Payment date: 31st May 2024 Dividend yield will be 3.6%, which is higher than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (46% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 28% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 66% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • May 26Sinoma Science & Technology Co.,Ltd. Announces Final Cash Dividend on A Shares for 2023, Payable on 31 May 2024Sinoma Science & Technology Co.,Ltd. announced 2023 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 5.60000000. Record date: 30 May 2024; Ex-date: 31 May 2024; Payment date: 31 May 2024.
お知らせ • May 15Sinoma Science & Technology Co.,Ltd. Elects Zhang Wenjin as a DirectorSinoma Science & Technology Co.,Ltd. held its first Extraordinary General Meeting of 2024 on 13 May 2024, elected Zhang Wenjin as a director.
Major Estimate Revision • May 07Consensus EPS estimates increase by 15%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate increased from CN¥1.49 to CN¥1.71. Revenue forecast unchanged at CN¥29.7b. Net income forecast to grow 45% next year vs 54% growth forecast for Chemicals industry in China. Consensus price target of CN¥23.26 unchanged from last update. Share price rose 7.3% to CN¥16.66 over the past week.
Reported Earnings • Apr 26First quarter 2024 earnings: EPS and revenues miss analyst expectationsFirst quarter 2024 results: EPS: CN¥0.13 (down from CN¥0.25 in 1Q 2023). Revenue: CN¥4.43b (up 4.1% from 1Q 2023). Net income: CN¥216.2m (down 48% from 1Q 2023). Profit margin: 4.9% (down from 9.8% in 1Q 2023). Revenue missed analyst estimates by 14%. Earnings per share (EPS) also missed analyst estimates by 58%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 11% per year.
お知らせ • Mar 30Sinoma Science & Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024Sinoma Science & Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024
Major Estimate Revision • Mar 28Consensus EPS estimates fall by 27%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥30.1b to CN¥28.8b. EPS estimate also fell from CN¥2.04 per share to CN¥1.48 per share. Net income forecast to grow 12% next year vs 54% growth forecast for Chemicals industry in China. Consensus price target down from CN¥27.21 to CN¥22.52. Share price was steady at CN¥15.08 over the past week.
お知らせ • Mar 23Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 12, 2024Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 12, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Beijing China Agenda: To consider 2023 annual report and its summary; to consider 2023 work report of the board of directors; to consider 2023 work report of the supervisory committee; to consider 2023 annual accounts report; to consider 2023 profit distribution plan; to consider 2024 estimated continuing connected transactions; to consider Amendments to the system for independent directors; to consider Amendments to the Company's articles of association; to consider 2024 loan budget and authorization for relevant loans; to consider Application for registration and issuance of not more than CNY 4.8 billion super and short-term commercial papers at a proper time; to consider Application for registration and issuance of not more than CNY 0.9 billion commercial papers; to consider Reappointment of 2024 audit firm; to consider Election of Wang Li as a supervisor.
New Risk • Mar 23New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 22% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks High level of debt (43% net debt to equity). Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (8.6% net profit margin).
Price Target Changed • Mar 22Price target decreased by 11% to CN¥25.94Down from CN¥29.11, the current price target is an average from 5 analysts. New target price is 70% above last closing price of CN¥15.27. Stock is down 39% over the past year. The company is forecast to post earnings per share of CN¥1.49 for next year compared to CN¥1.33 last year.
Reported Earnings • Mar 22Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2023 results: EPS: CN¥1.33 (down from CN¥2.09 in FY 2022). Revenue: CN¥25.9b (up 17% from FY 2022). Net income: CN¥2.22b (down 37% from FY 2022). Profit margin: 8.6% (down from 16% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.6%. Earnings per share (EPS) missed analyst estimates by 15%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings.
Buy Or Sell Opportunity • Feb 06Now 29% overvaluedOver the last 90 days, the stock has fallen 21% to CN¥13.94. The fair value is estimated to be CN¥10.77, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.7% over the last 3 years. Earnings per share has grown by 11%. Revenue is forecast to grow by 49% in 2 years. Earnings are forecast to grow by 46% in the next 2 years.
Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥12.68, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥10.87 per share.
お知らせ • Dec 30Sinoma Science & Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 22, 2024Sinoma Science & Technology Co.,Ltd. announced that they will report fiscal year 2023 results on Mar 22, 2024
Major Estimate Revision • Oct 30Consensus EPS estimates fall by 33%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥26.2b to CN¥25.7b. EPS estimate also fell from CN¥2.01 per share to CN¥1.34 per share. Net income forecast to grow 17% next year vs 60% growth forecast for Chemicals industry in China. Consensus price target down from CN¥29.11 to CN¥27.81. Share price fell 5.3% to CN¥17.28 over the past week.
New Risk • Oct 24New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 18% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (18% operating cash flow to total debt). High level of non-cash earnings (22% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows.
New Risk • Aug 19New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 20% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (20% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows.
